Scientific Frontline: "At a Glance" Summary
- Main Discovery: Researchers engineered a novel DNA polymerase, designated C28, that efficiently synthesizes RNA with high fidelity and speed, a capability that natural DNA polymerases are biologically designed to reject.
- Methodology: The team utilized directed evolution within a high-throughput, single-cell screening platform to recombine related polymerase genes, evaluating millions of variants to identify unexpected structural solutions without manually redesigning the active site.
- Key Data: The C28 enzyme contains dozens of specific mutations selected from a pool of millions of variants, enabling it to operate at near-natural speeds while accommodating chemically modified RNA building blocks.
- Significance: This breakthrough overcomes fundamental biological barriers to RNA synthesis, creating a versatile tool that can also perform reverse transcription and generate hybrid DNA-RNA molecules using standard PCR techniques.
- Future Application: The enzyme provides critical functionality for developing next-generation mRNA vaccines and RNA-based therapeutics that require customized or chemically modified RNA sequences.
- Branch of Science: Biochemistry, Pharmaceutical Sciences, and Synthetic Biology.
- Additional Detail: Led by Professor John Chaput and published in Nature Chemical Biology, this research demonstrates that directed evolution can unlock molecular functions nonexistent in nature, such as the ability of a DNA polymerase to transcribe RNA.






.jpg)


